BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 16441428)

  • 1. Epstein-Barr virus involvement is a predictive factor for the resistance to chemoradiotherapy of gastric diffuse large B-cell lymphoma.
    Yoshino T; Nakamura S; Matsuno Y; Ochiai A; Yokoi T; Kitadai Y; Suzumiya J; Tobinai K; Kobayashi Y; Oda I; Mera K; Ohtsu A; Ishikura S
    Cancer Sci; 2006 Feb; 97(2):163-6. PubMed ID: 16441428
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epstein-Barr virus (EBV) positive diffuse large B cell lymphoma of the elderly-experience of a single center from Turkey.
    Ozsan N; Cagirgan S; Saydam G; Gunes A; Hekimgil M
    Pathol Res Pract; 2013 Aug; 209(8):471-8. PubMed ID: 23726928
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinicopathological features of Epstein-Barr virus-positive diffuse large B-cell lymphoma in elderly].
    Xu FP; Liu YH; Zhuang HG; Luo DL; Li L; Zhang F; Luo XL; Du X; Li WY; Chen Q
    Zhonghua Bing Li Xue Za Zhi; 2011 Sep; 40(9):616-21. PubMed ID: 22177246
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Whole blood EBV-DNA predicts outcome in diffuse large B-cell lymphoma.
    Tisi MC; Cupelli E; Santangelo R; Maiolo E; Alma E; Giachelia M; Martini M; Bellesi S; D'Alò F; Voso MT; Pompili M; Leone G; Larocca LM; Hohaus S
    Leuk Lymphoma; 2016; 57(3):628-34. PubMed ID: 26458141
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A malignant lymphoma with histological features and immunophenotypic profile intermediate between EBV-positive diffuse large B-cell lymphoma and EBV-positive classical Hodgkin lymphoma in a 67-year-old female: a "gray zone" lymphoma associated with Epstein-Barr virus in the elderly.
    Wang E; Papavassiliou P; Sebastian S
    Pathol Res Pract; 2012 Jun; 208(6):363-7. PubMed ID: 22572037
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Successful treatment of refractory retroperitoneal Epstein-Barr virus-positive diffuse large B-cell lymphoma with secondary hemophagocytic syndrome by sequential combination regimen of PD-1 blockade and chimeric antigen receptor T cells: a case report.
    Yu M; Zhang Q; Xu S; Yin T; Li F
    Anticancer Drugs; 2022 Jan; 33(1):e769-e775. PubMed ID: 34387604
    [TBL] [Abstract][Full Text] [Related]  

  • 7. EBV-positive large B-cell lymphomas in young patients: a nodal lymphoma with evidence for a tolerogenic immune environment.
    Nicolae A; Pittaluga S; Abdullah S; Steinberg SM; Pham TA; Davies-Hill T; Xi L; Raffeld M; Jaffe ES
    Blood; 2015 Aug; 126(7):863-72. PubMed ID: 25999451
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epstein-Barr virus infection in Richter's transformation.
    Ansell SM; Li CY; Lloyd RV; Phyliky RL
    Am J Hematol; 1999 Feb; 60(2):99-104. PubMed ID: 9929100
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantification of plasma Epstein-Barr virus DNA for assessing treatment response in a patient with plasmablastic lymphoma.
    Law MF; Poon WL; Ng KS; Chan HN; Lai HK; Ha CY; Ng C; Yeung YM; Yip SF
    Ann Hematol; 2012 May; 91(5):789-791. PubMed ID: 21881823
    [No Abstract]   [Full Text] [Related]  

  • 10. Epstein-Barr Virus-Positive Diffuse Large B-Cell Lymphoma in the Elderly: A Matched Case-Control Analysis.
    Song CG; Huang JJ; Li YJ; Xia Y; Wang Y; Bi XW; Jiang WQ; Huang HQ; Lin TY; Li ZM
    PLoS One; 2015; 10(7):e0133973. PubMed ID: 26222726
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical outcome of elderly patients with Epstein-Barr virus positive diffuse large B-cell lymphoma treated with a combination of rituximab and CHOP chemotherapy.
    Ahn JS; Yang DH; Duk Choi Y; Jung SH; Yhim HY; Kwak JY; Sung Park H; Shin MG; Kim YK; Kim HJ; Lee JJ
    Am J Hematol; 2013 Sep; 88(9):774-9. PubMed ID: 23760676
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical outcome of Epstein-Barr virus-positive diffuse large B-cell lymphoma of the elderly in the rituximab era.
    Sato A; Nakamura N; Kojima M; Ohmachi K; Carreras J; Kikuti YY; Numata H; Ohgiya D; Tazume K; Amaki J; Moriuchi M; Miyamoto M; Aoyama Y; Kawai H; Ichiki A; Hara R; Kawada H; Ogawa Y; Ando K
    Cancer Sci; 2014 Sep; 105(9):1170-5. PubMed ID: 24974976
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epstein-Barr virus detection in non-Hodgkin's lymphoma of the oral cavity: an immunocytochemical and in situ hybridization study.
    Leong IT; Fernandes BJ; Mock D
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2001 Aug; 92(2):184-93. PubMed ID: 11505266
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Secondary cutaneous Epstein-Barr virus-associated diffuse large B-cell lymphoma in a patient with angioimmunoblastic T-cell lymphoma: a case report and review of literature.
    Yang QX; Pei XJ; Tian XY; Li Y; Li Z
    Diagn Pathol; 2012 Jan; 7():7. PubMed ID: 22260632
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [EBV-positive diffuse large B-cell lymphoma in young individual: report of a case].
    Li WS; Xie JL; Zhang M; Zhou XG
    Zhonghua Bing Li Xue Za Zhi; 2013 Feb; 42(2):128-9. PubMed ID: 23710923
    [No Abstract]   [Full Text] [Related]  

  • 16. Epstein-Barr virus-induced transformation of cutaneous plasmacytoma into CD30+ diffuse large B-cell lymphoma.
    Donner LR
    Am J Dermatopathol; 2004 Feb; 26(1):63-6. PubMed ID: 14726824
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical impact of serum survivin positivity and tissue expression of EBV-encoded RNA in diffuse large B-cell lymphoma patients treated with rituximab-CHOP.
    Hong JY; Ryu KJ; Park C; Hong M; Ko YH; Kim WS; Kim SJ
    Oncotarget; 2017 Feb; 8(8):13782-13791. PubMed ID: 28099151
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of an early intensification treatment integrating chemotherapy, autologous stem cell transplantation and radiotherapy for poor risk primary mediastinal large B cell lymphoma with sclerosis.
    Cairoli R; Grillo G; Tedeschi A; Gargantini L; Marenco P; Tresoldi E; Barbarano L; Nosari AM; Morra E
    Bone Marrow Transplant; 2002 Mar; 29(6):473-7. PubMed ID: 11960265
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reappraisal of Primary Epstein-Barr Virus (EBV)-positive Diffuse Large B-Cell Lymphoma of the Gastrointestinal Tract: Comparative Analysis Among Immunosuppressed and Nonimmunosuppressed Stage I and II-IV Patients.
    Miyagi S; Ishikawa E; Nakamura M; Shimada K; Yamamura T; Furukawa K; Tanaka T; Mabuchi S; Tsuyuki Y; Kohno K; Sakakibara A; Satou A; Kato S; Fujishiro M; Nakamura S
    Am J Surg Pathol; 2020 Sep; 44(9):1173-1183. PubMed ID: 32349049
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Composite B-cell and T-cell lymphomas: clinical, pathological, and molecular features of three cases and literature review.
    Jin X; Liu H; Li J; Xiao X; Yuan X; Chen P; Chen B; Liang Y; Huang F
    J Zhejiang Univ Sci B; 2023 Aug; 24(8):711-722. PubMed ID: 37551557
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.